Heart disease is the leading cause of death for Americans. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are working to understand how to reduce our risk of heart attacks, stroke, and other cardiovascular diseases throughout life.
Addressing risk factors, improving diagnosis, and exploring how medications, genes, and everyday life affect our cardiovascular health at different ages and stages are central to this work — as is translating research findings into practical, personalized care.
“We’ve found that helping patients and health care teams work together on personalized care plans is the best path to lifelong heart health,” says Beverly Green, MD, MPH, whose recent work has focused on improving the diagnosis of high blood pressure.
Additional focus areas for KPWHRI scientists include exploring the impact of cardiovascular diseases on other health conditions — and vice versa. Recently, this has led researchers Sascha Dublin, MD, PhD, and Laura B. Harrington, PhD, MPH, to investigate the impact of COVID-19 on cardiovascular health.
Below are other research highlights from KPWHRI’s cardiovascular health scientists (please visit their bios to learn more):
Black MH, Zhou H, Sacks DA, Dublin S, Lawrence JM, Harrison TN, Reynolds K. Prehypertension prior to or during early pregnancy is associated with increased risk for hypertensive disorders in pregnancy and gestational diabetes. J Hypertens. 2015 Sep;33(9):1860-7. doi: 10.1097/HJH.0000000000000646. PubMed
Langefeld CD, Gottesman R, Mosley TH, Shahar E, Woo D, Yaffe K, Liu Y, Sale MM, Dichgans M, Malik R, Longstreth WT Jr, Mitchell BD, Psaty BM, Kooperberg C, Reiner A, Worrall BB, Fornage M. Social and emotional learning services and child outcomes in third grade: evidence from a cohort of head start participants. Stroke. 2015 Aug;46(8):2063-8. doi: 10.1161/STROKEAHA.115.009044. Epub 2015. Jun 18. PubMed
Desai JR1, Vazquez-Benitez G2, Xu Z2, Schroeder EB2, Karter AJ2, Steiner JF2, Nichols GA, Reynolds K, Xu S, Newton K, Pathak RD, Waitzfelder B, Elston Lafata J, Butler MG, Kirchner HL, Thomas A, O'Connor PJ. Who must we target now to minimize future cardiovascular events and total mortality? lessons from the supreme-dm cohort study. Circ Cardiovasc Qual Outcomes. 2015 Aug 25. pii: CIRCOUTCOMES.115.001717. [Epub ahead of print]. PubMed
Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL, Folsom AR. Orthostatic hypotension and risk of venous thromboembolism in 2 cohort studies. Am J Hypertens. 2015 Aug 25. pii: hpv151. [Epub ahead of print]. PubMed
Reynolds LM, Wan M, Ding J, Taylor JR, Lohman K, Su D, Bennett BD, Porter DK, Gimple R, Pittman GS, Wang X, Howard TD, Siscovick D, Psaty BM, Shea S, Burke GL, Jacobs DR Jr, Rich SS, Hixson JE, Stein JH, Stunnenberg H, Barr RG, Kaufman JD, Post WS, Hoeschele I, Herrington DM, Bell DA, Liu Y. DNA methylation of the aryl hydrocarbon receptor repressor associations with cigarette smoking and subclinical atherosclerosis. Circ Cardiovasc Genet. 2015 Aug 25. pii: CIRCGENETICS.115.001097. [Epub ahead of print]. PubMed
Sascha Dublin, MD, PhDSenior Investigator |
Beverly B. Green, MD, MPHSenior Investigator |
Laura Harrington, PhD, MPHAssistant Investigator |
Ellen O'Meara, PhDPrincipal Collaborative Scientist |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
Meagan C. Brown, PhD, MPHAssistant Investigator |
James Floyd, MD, MS
Assistant Professor, Department of Medicine
Adjunct Assistant Professor, Department of Epidemiology
University of Washington
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
Nicholas L. Smith, PhD, MPH
UW Professor, Epidemiology, Cardiovascular Health Research Unit
Director, Seattle Epidemiology and Information Resource Center, VA Puget Sound Health Care System